A simple method for assessment of MDR bacteria for over-expressed Efflux pumps

Open Microbiology Journal

Volumn 7, Issue SPEC.ISSUE.1, 2013, Pages 72-82

  Martins, Marta ^a,b   Mccusker, Matthew P ^a,b   Viveiros, Miguel ^b,c   Couto, Isabel ^c,d   Fanning, Séamus ^a,b   Pagès, Jean Marie ^b,e   Amaral, Leonard ^b,c  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b Cost Action BM0701 ^*  (Greece)

^c INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^d UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^e Aix Marseille University   (France)

Author keywords

Clinical isolates; Efflux activity; Efflux pumps; Ethidium bromide; Multi drug resistance; Screening method

Indexed keywords

2 NAPHTHYLAMINE; CARBAPENEM; CHLORPROMAZINE; CIPROFLOXACIN; ETHIDIUM BROMIDE; IMIPENEM; NORFLOXACIN; PHENYLALANINE ARGININE BETA NAPHTHYLAMIDE; TETRACYCLINE; THIORIDAZINE; UNCLASSIFIED DRUG;

ACINETOBACTER; AGAR CARTWHEEL METHOD; ANALYTIC METHOD; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; ENTEROBACTER AEROGENES; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FLUORESCENCE ANALYSIS; GENE OVEREXPRESSION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; ION TRANSPORT; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALMONELLA ENTERICA; SALMONELLA ENTERITIDIS; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; TEMPERATURE SENSITIVITY;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 84876073170     PISSN: None     EISSN: 18742858     Source Type: Journal    
DOI: 10.2174/1874285801307010072     Document Type: Review

References (35)

1. Theuretzbacher U. Accelerating resistance, inadequate antibacterial drug pipelines and international responses. Int J Antimicrob Agents 2012; 39: 295-9.
2. Henriques Normark B, Normark S. Antibiotic tolerance in pneumococci. Clin Microbiol Infect 2002; 8: 13-22.
3. Piddock LJ. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 2006; 19: 382-402.
4. Viveiros M, Martins A, Paixão L, et al. Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method. Int J Antimicrob Agents 2008; 31: 458-62.
5. Viveiros M, Martins M, Couto I, et al. New methods for the identification of efflux mediated MDR bacteria, genetic assessment of regulators and efflux pump constituents, characterization of efflux systems and screening for inhibitors of efflux pumps. Curr Drug Targets 2008; 9: 760-78.
6. Amaral L, Cerca P, Spengler G, et al. Ethidium bromide efflux by Salmonella: modulation by metabolic energy, pH, ions and phenothiazines. Int J Antimicrob Agents 2011; 38: 140-5.
7. Jernaes MW, Steen HB. Staining of Escherichia coli for flow cytometry: influx and efflux of ethidium bromide. Cytometry 1994; 17: 302-9.
8. Amaral L, Fanning S, Pagès JM. Efflux pumps of gram-negative bacteria: genetic responses to stress and the modulation of their activity by pH, inhibitors, and phenothiazines. Adv Enzymol Relat Areas Mol Biol 2011; 77: 61-108.
9. Klein JS, Lewinson O. Bacterial ATP-driven transporters of transition metals: physiological roles, mechanisms of action, and roles in bacterial virulence. Metallomics 2011; 3: 1098-108.
10. Looser V, Hammes F, Keller M, Berney M, Kovar K, Egli T. Flowcytometric detection of changes in the physiological state of E. coli expressing a heterologous membrane protein during carbon-limited fedbatch cultivation. Biotechnol Bioeng 2005; 92: 69-78.
11. Viveiros M, Dupont M, Rodrigues L, et al. Antibiotic stress, genetic response and altered permeability of E. coli. PLoS ONE 2007; 2: e365.
12. Viveiros M, Rodrigues L, Martins M, et al. Evaluation of efflux activity of bacteria by a semi-automated fluorometric system. Methods Mol Biol 2010; 642: 159-72.
13. Matsumoto Y, Hayama K, Sakakihara S, et al. Evaluation of multidrug efflux pump inhibitors by a new method using microfluidic channels. PLoS ONE 2011; 6: e18547.
14. Coldham NG, Webber M, Woodward MJ, Piddock LJ. A 96-well plate fluorescence assay for assessment of cellular permeability and active efflux in Salmonella enterica serovar Typhimurium and Escherichia coli. J Antimicrob Chemother 2010; 65: 1655-63.
15. Bohnert JA, Karamian B, Nikaido H. Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates. Antimicrob Agents Chemother 2010; 54: 3770-5.
16. Martins M, Santos B, Martins A, et al. 2006. An instrument-free method for the demonstration of efflux pump activity of bacteria. In Vivo 20: 657-64.
17. Kamicker BJ, Sweeney MT, Kaczmarek F, et al. Bacterial efflux pump inhibitors. Methods Mol Med 2008; 142: 187-204.
18. Pagès JM, Masi M, Barbe J. Inhibitors of efflux pumps in Gram negative bacteria. Trends Mol Med 2005; 11: 382-9.
19. Pagès JM, Amaral L, Fanning S. An original deal for new molecule: reversal of efflux pump activity, a rational strategy to combat gram-negative resistant bacteria. Curr Med Chem 2011; 18: 2969-80.
20. Martins M, Dastidar SG, Fanning S, et al. Potential role of non antibiotics (helper compounds) in the treatment of multidrug resistant Gram-negative infections: mechanisms for their direct and indirect activities. Int J Antimicrob Agents 2008; 31: 198-208.
21. Martins M, Viveiros M, Couto I, et al. Identification of efflux pump-mediated multidrug-resistant bacteria by the ethidium bromide-agar cartwheel method. In Vivo 2011; 25: 171-8.
22. Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J Infect Control 2006; 34(5 Suppl 1): S3-10.
23. Viveiros M, Jesus A, Brito M, et al. Inducement and reversal of tetracycline resistance in Escherichia coli K-12 and the expression of proton gradient dependent multidrug efflux pump genes. Antimicrob Agents Chemother 2005; 49: 3578-82.
24. Okuso H, Ma D, Nikaido H. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple antibiotic-resistance (Mar) mutants. J Bacteriol 1996; 178: 306-8.
25. Quinn T, O'Mahony R, Baird AW, Drudy D, Whyte P, Fanning S. Multi-drug resistance in Salmonella enterica: efflux mechanisms and their relationships with the development of chromosomal resistance gene clusters. Curr Drug Targets 2006; 7: 849-60.
26. O'Regan E, Quinn T, Pagès JM, McCusker M, Piddock L, Fanning S. Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators. Antimicrob Agents Chemother 2009; 53: 1080-7.
27. Couto I, Costa SS, Viveiros M, Martins M, Amaral L. Effluxmediated response of Staphylococcus aureus exposed to ethidium bromide. J Antimicrob Chemother 2008; 62: 504-13.
28. Kumar A, Schweizer HP. Bacterial resistance to antibiotics: active efflux and reduced uptake. Adv Drug Deliv Rev 2005; 57: 1486-513.
29. Nelson ML. Modulation of antibiotic efflux in bacteria. Curr Med Chem 2002; 1: 35-54.
30. Lomovskaya O, Warren MS, Lee A, et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 2001; 45: 105-16.
31. Webber MA, Piddock LJV. The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother 2003; 51: 9-11.
32. Bhardwaj AK, Mohanty P. Bacterial Efflux Pumps Involved in Multidrug Resistance and their Inhibitors: Rejuvenating the Antimicrobial Chemotherapy. Recent Pat Antiinfect Drug Discov 2012; 7: 73-89.
33. Kristiansen JE, Amaral L. The potential management of resistant infections with non-antibiotics. J Antimicrob Chemother 1997; 40: 319-27.
34. Zgurskaya HI, Nikaido H. Multidrug resistance mechanisms: drug efflux across two membranes. Mol Microb 2000; 37: 219-25
35. Martins M, Couto I, Viveiros M, Amaral L. Identification of efflux. mediated multi-drug resistance in bacterial clinical isolates by two simple methods. Methods Mol Biol 2010; 642: 143-57.